| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Business Officer
2 companies
Springhorn Jeremy P. is a Director at uniQure N.V. with holdings across 2 companies. Recent SEC Form 4 filings include 3 buys and 9 sells.
Estimated insider holdings value: $1.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | QURE Uniqure N.V. | Director | Sell | 2,112 | $14.45 | $30,518.40 | -5.3% | +3.7% | - | |
| Jun 13, 2024 | QURE Uniqure N.V. | Director | Sell | 2,231 | $5.12 | $11,422.72 | -8.6% | +4.2% | +192.2% | |
| Jun 16, 2023 | QURE Uniqure N.V. | Director | Sell | 2,286 | $18.88 | $43,159.68 | -8.1% | -60.6% | -74.9% | |
| Feb 27, 2023 | QURE Uniqure N.V. | Director | Sell | 384 | $20.41 | $7,837.44 | -1.9% | -8.4% | -67.9% | |
| Feb 28, 2022 | QURE Uniqure N.V. | Director | Sell | 602 | $16.70 | $10,053.40 | -5.2% | -15.5% | +23.4% | |
| Mar 2, 2021 | QURE Uniqure N.V. | Director | Sell | 505 | $37.50 | $18,937.50 | -4.8% | - | - | |
| Jan 28, 2020 | QURE Uniqure N.V. | Director | Sell | 807 | $62.19 | $50,190.36 | -5.9% | - | - | |
| Nov 12, 2019 | SYRS Syros Pharmaceuticals, Inc. | Chief Business Officer | Buy | 20,000 | $4.98 | $99,595.79 | +50.2% | - | - | |
| Jan 28, 2019 | QURE Uniqure N.V. | Director | Sell | 1,210 | $31.32 | $37,897.20 | -15.1% | - | - | |
| Dec 15, 2017 | SYRS Syros Pharmaceuticals, Inc. | Chief Business Officer | Buy | 15,000 | $9.08 | $136,260.00 | New | - | - |